Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.
about
Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and TreatmentMultiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosisMicro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cellsCellular retinoic acid-binding protein 2 inhibits tumor growth by two distinct mechanisms.The pathoetiology of neurofibromatosis 1The flip-flop HuR: part of the problem or the solution in fighting cancer?Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4+ T CellsRab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.Genetic polymorphisms in RNA binding proteins contribute to breast cancer survivalIncisional hernia recurrence through genomic profiling: a pilot study.Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Posttranscriptional gene regulation of IL-17 by the RNA-binding protein HuR is required for initiation of experimental autoimmune encephalomyelitisConditional knockout of the RNA-binding protein HuR in CD4⁺ T cells reveals a gene dosage effect on cytokine productionTherapies using anti-angiogenic peptide mimetics of thrombospondin-1.PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Ribonuclease activity of p53 in cytoplasm in response to various stress signals.Transcript stabilization by the RNA-binding protein HuR is regulated by cellular retinoic acid-binding protein 2.Method for the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts using RIP-Chip.Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.RNA Binding Protein as an Emerging Therapeutic Target for Cancer Prevention and Treatment.Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFβ signaling.The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.
P2860
Q28075325-E42B7FA3-B504-44D8-9DF8-77BB64667A6EQ28290458-B9C718F8-EF5F-4087-AA20-8C0915732FBBQ33585105-6A984A57-76A1-4604-83A0-ED5B11BFBE42Q34307356-94FCA06C-5EEE-4396-B486-A5B2DBDD7B2DQ34491276-3E9067A9-72E6-4E97-8B52-720C0A3C5DA9Q34634211-9ECE3428-6811-4AD2-B974-4DE7DB70B206Q34838523-BF2CFFC5-BA62-43B0-9BCD-40C056CB9265Q35640668-5D23D470-80D6-42A2-A14F-0B1ACFE43139Q35688280-2EE427CF-D075-4E1C-894A-06F478A1C60CQ36403091-C0D753E5-E898-42C5-BE65-96A5FE123421Q36428838-AFDFEF81-47EF-4E17-8B20-4B873887E2C5Q36710834-0A698101-8F67-425D-AD1C-CF7DA314735EQ36862768-E123C0D9-63EC-43DA-A5A7-F40B705A5519Q37317152-405BFC65-7888-4AF1-9E21-213F46E6E950Q37649960-547700F7-5E2F-47C0-9D2C-84C0331EFFADQ37963916-D9B5F280-B19A-4488-8D61-BB217431D894Q38794311-739B004D-A181-41EB-86C3-8F66BFCB82D4Q39036700-B79E51D0-E4F1-430C-9EBC-98110B108601Q39379098-C81D2FBD-7870-4AB7-B879-18696DF2D292Q40603538-9F57EE6C-5A18-4444-9194-76B748F4D5EFQ41461717-F95E079D-1020-473B-8AF5-F79D5BA6C052Q45929654-1D8BF02A-E888-4E38-90E3-BB56892841B2Q47129433-A4935AA6-B9F0-42EB-87AE-4B7D4839CB38Q47780400-A14ECFAD-3DE3-4B6B-BB3E-3061DCE66E6FQ48088391-7DEFAB63-944D-47E5-A74D-289B007AC2E7Q51054802-2DF0B921-9796-4971-8122-FF9FC7E13A01
P2860
Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@ast
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@en
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@nl
type
label
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@ast
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@en
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@nl
prefLabel
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@ast
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@en
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@nl
P2093
P2860
P356
P1433
P1476
Overexpression of the RNA bind ...... d with deficient angiogenesis.
@en
P2093
Ashley Brown
Connie S Strouse
Daniel P Shaw
J Wade Davis
Joseph D Magee
Matthew M Gubin
Robert Calaluce
Tammy L Rold
Timothy Hoffman
P2860
P304
P356
10.4161/CC.9.16.12711
P577
2010-08-17T00:00:00Z